Global NAD+ Intravenous Therapy Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
154
Industry
Therapeutic Area
Regions
Global
Updated
April 2026

Report Overview


Report Overview
NAD+ IV Therapy is a wellness therapy that involves the intravenous administration of nicotinamide adenine dinucleotide (NAD+), a coenzyme crucial for cellular energy production and metabolic processes. This therapy is believed to boost energy levels, enhance cognitive function, and promote overall cellular repair by increasing NAD+ levels, which naturally decline with age.

The global NAD+ Intravenous Therapy market size was estimated at USD 291.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global NAD+ Intravenous Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global NAD+ Intravenous Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the NAD+ Intravenous Therapy market.
Global NAD+ Intravenous Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
The Wellness Lab
Conciergemdla
Azivmedics
Reset IV
Thedripclub
Toronto Functional Medicine Centre
Mobileivmedics
Rocky Mountain Ivmedics
Seaside Skin Care
Premiumhealth
Effect Doctors
Nadclinic
Hydrate IV Bar
LIVV Natural
BioReset Medical
IV Boost UK

Market Segmentation (by Type)
NAD+ Mixed Vitamin Injections
Pure NAD+ Injection

Market Segmentation (by Application)
Clinic
Hospital
Residential

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the NAD+ Intravenous Therapy Market
Overview of the regional outlook of the NAD+ Intravenous Therapy Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NAD+ Intravenous Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of NAD+ Intravenous Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of NAD+ Intravenous Therapy
    • 1.2 Key Market Segments
      • 1.2.1 NAD+ Intravenous Therapy Segment by Type
      • 1.2.2 NAD+ Intravenous Therapy Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 NAD+ Intravenous Therapy Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global NAD+ Intravenous Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global NAD+ Intravenous Therapy Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 NAD+ Intravenous Therapy Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global NAD+ Intravenous Therapy Product Life Cycle
    • 3.3 Global NAD+ Intravenous Therapy Sales by Manufacturers (2020-2025)
    • 3.4 Global NAD+ Intravenous Therapy Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 NAD+ Intravenous Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global NAD+ Intravenous Therapy Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 NAD+ Intravenous Therapy Market Competitive Situation and Trends
      • 3.8.1 NAD+ Intravenous Therapy Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest NAD+ Intravenous Therapy Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 NAD+ Intravenous Therapy Industry Chain Analysis
    • 4.1 NAD+ Intravenous Therapy Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of NAD+ Intravenous Therapy Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global NAD+ Intravenous Therapy Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to NAD+ Intravenous Therapy Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 NAD+ Intravenous Therapy Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global NAD+ Intravenous Therapy Sales Market Share by Type (2020-2025)
    • 6.3 Global NAD+ Intravenous Therapy Market Size by Type (2020-2025)
    • 6.4 Global NAD+ Intravenous Therapy Price by Type (2020-2025)
  • 7 NAD+ Intravenous Therapy Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global NAD+ Intravenous Therapy Market Sales by Application (2020-2025)
    • 7.3 Global NAD+ Intravenous Therapy Market Size (M USD) by Application (2020-2025)
    • 7.4 Global NAD+ Intravenous Therapy Sales Growth Rate by Application (2020-2025)
  • 8 NAD+ Intravenous Therapy Market Sales by Region
    • 8.1 Global NAD+ Intravenous Therapy Sales by Region
      • 8.1.1 Global NAD+ Intravenous Therapy Sales by Region
      • 8.1.2 Global NAD+ Intravenous Therapy Sales Market Share by Region
    • 8.2 Global NAD+ Intravenous Therapy Market Size by Region
      • 8.2.1 Global NAD+ Intravenous Therapy Market Size by Region
      • 8.2.2 Global NAD+ Intravenous Therapy Market Size by Region
    • 8.3 North America
      • 8.3.1 North America NAD+ Intravenous Therapy Sales by Country
      • 8.3.2 North America NAD+ Intravenous Therapy Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe NAD+ Intravenous Therapy Sales by Country
      • 8.4.2 Europe NAD+ Intravenous Therapy Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific NAD+ Intravenous Therapy Sales by Region
      • 8.5.2 Asia Pacific NAD+ Intravenous Therapy Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America NAD+ Intravenous Therapy Sales by Country
      • 8.6.2 South America NAD+ Intravenous Therapy Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa NAD+ Intravenous Therapy Sales by Region
      • 8.7.2 Middle East and Africa NAD+ Intravenous Therapy Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 NAD+ Intravenous Therapy Market Production by Region
    • 9.1 Global Production of NAD+ Intravenous Therapy by Region(2020-2025)
    • 9.2 Global NAD+ Intravenous Therapy Revenue Market Share by Region (2020-2025)
    • 9.3 Global NAD+ Intravenous Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America NAD+ Intravenous Therapy Production
      • 9.4.1 North America NAD+ Intravenous Therapy Production Growth Rate (2020-2025)
      • 9.4.2 North America NAD+ Intravenous Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe NAD+ Intravenous Therapy Production
      • 9.5.1 Europe NAD+ Intravenous Therapy Production Growth Rate (2020-2025)
      • 9.5.2 Europe NAD+ Intravenous Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan NAD+ Intravenous Therapy Production (2020-2025)
      • 9.6.1 Japan NAD+ Intravenous Therapy Production Growth Rate (2020-2025)
      • 9.6.2 Japan NAD+ Intravenous Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China NAD+ Intravenous Therapy Production (2020-2025)
      • 9.7.1 China NAD+ Intravenous Therapy Production Growth Rate (2020-2025)
      • 9.7.2 China NAD+ Intravenous Therapy Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 The Wellness Lab
      • 10.1.1 The Wellness Lab Basic Information
      • 10.1.2 The Wellness Lab NAD+ Intravenous Therapy Product Overview
      • 10.1.3 The Wellness Lab NAD+ Intravenous Therapy Product Market Performance
      • 10.1.4 The Wellness Lab Business Overview
      • 10.1.5 The Wellness Lab SWOT Analysis
      • 10.1.6 The Wellness Lab Recent Developments
    • 10.2 Conciergemdla
      • 10.2.1 Conciergemdla Basic Information
      • 10.2.2 Conciergemdla NAD+ Intravenous Therapy Product Overview
      • 10.2.3 Conciergemdla NAD+ Intravenous Therapy Product Market Performance
      • 10.2.4 Conciergemdla Business Overview
      • 10.2.5 Conciergemdla SWOT Analysis
      • 10.2.6 Conciergemdla Recent Developments
    • 10.3 Azivmedics
      • 10.3.1 Azivmedics Basic Information
      • 10.3.2 Azivmedics NAD+ Intravenous Therapy Product Overview
      • 10.3.3 Azivmedics NAD+ Intravenous Therapy Product Market Performance
      • 10.3.4 Azivmedics Business Overview
      • 10.3.5 Azivmedics SWOT Analysis
      • 10.3.6 Azivmedics Recent Developments
    • 10.4 Reset IV
      • 10.4.1 Reset IV Basic Information
      • 10.4.2 Reset IV NAD+ Intravenous Therapy Product Overview
      • 10.4.3 Reset IV NAD+ Intravenous Therapy Product Market Performance
      • 10.4.4 Reset IV Business Overview
      • 10.4.5 Reset IV Recent Developments
    • 10.5 Thedripclub
      • 10.5.1 Thedripclub Basic Information
      • 10.5.2 Thedripclub NAD+ Intravenous Therapy Product Overview
      • 10.5.3 Thedripclub NAD+ Intravenous Therapy Product Market Performance
      • 10.5.4 Thedripclub Business Overview
      • 10.5.5 Thedripclub Recent Developments
    • 10.6 Toronto Functional Medicine Centre
      • 10.6.1 Toronto Functional Medicine Centre Basic Information
      • 10.6.2 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product Overview
      • 10.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product Market Performance
      • 10.6.4 Toronto Functional Medicine Centre Business Overview
      • 10.6.5 Toronto Functional Medicine Centre Recent Developments
    • 10.7 Mobileivmedics
      • 10.7.1 Mobileivmedics Basic Information
      • 10.7.2 Mobileivmedics NAD+ Intravenous Therapy Product Overview
      • 10.7.3 Mobileivmedics NAD+ Intravenous Therapy Product Market Performance
      • 10.7.4 Mobileivmedics Business Overview
      • 10.7.5 Mobileivmedics Recent Developments
    • 10.8 Rocky Mountain Ivmedics
      • 10.8.1 Rocky Mountain Ivmedics Basic Information
      • 10.8.2 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product Overview
      • 10.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product Market Performance
      • 10.8.4 Rocky Mountain Ivmedics Business Overview
      • 10.8.5 Rocky Mountain Ivmedics Recent Developments
    • 10.9 Seaside Skin Care
      • 10.9.1 Seaside Skin Care Basic Information
      • 10.9.2 Seaside Skin Care NAD+ Intravenous Therapy Product Overview
      • 10.9.3 Seaside Skin Care NAD+ Intravenous Therapy Product Market Performance
      • 10.9.4 Seaside Skin Care Business Overview
      • 10.9.5 Seaside Skin Care Recent Developments
    • 10.10 Premiumhealth
      • 10.10.1 Premiumhealth Basic Information
      • 10.10.2 Premiumhealth NAD+ Intravenous Therapy Product Overview
      • 10.10.3 Premiumhealth NAD+ Intravenous Therapy Product Market Performance
      • 10.10.4 Premiumhealth Business Overview
      • 10.10.5 Premiumhealth Recent Developments
    • 10.11 Effect Doctors
      • 10.11.1 Effect Doctors Basic Information
      • 10.11.2 Effect Doctors NAD+ Intravenous Therapy Product Overview
      • 10.11.3 Effect Doctors NAD+ Intravenous Therapy Product Market Performance
      • 10.11.4 Effect Doctors Business Overview
      • 10.11.5 Effect Doctors Recent Developments
    • 10.12 Nadclinic
      • 10.12.1 Nadclinic Basic Information
      • 10.12.2 Nadclinic NAD+ Intravenous Therapy Product Overview
      • 10.12.3 Nadclinic NAD+ Intravenous Therapy Product Market Performance
      • 10.12.4 Nadclinic Business Overview
      • 10.12.5 Nadclinic Recent Developments
    • 10.13 Hydrate IV Bar
      • 10.13.1 Hydrate IV Bar Basic Information
      • 10.13.2 Hydrate IV Bar NAD+ Intravenous Therapy Product Overview
      • 10.13.3 Hydrate IV Bar NAD+ Intravenous Therapy Product Market Performance
      • 10.13.4 Hydrate IV Bar Business Overview
      • 10.13.5 Hydrate IV Bar Recent Developments
    • 10.14 LIVV Natural
      • 10.14.1 LIVV Natural Basic Information
      • 10.14.2 LIVV Natural NAD+ Intravenous Therapy Product Overview
      • 10.14.3 LIVV Natural NAD+ Intravenous Therapy Product Market Performance
      • 10.14.4 LIVV Natural Business Overview
      • 10.14.5 LIVV Natural Recent Developments
    • 10.15 BioReset Medical
      • 10.15.1 BioReset Medical Basic Information
      • 10.15.2 BioReset Medical NAD+ Intravenous Therapy Product Overview
      • 10.15.3 BioReset Medical NAD+ Intravenous Therapy Product Market Performance
      • 10.15.4 BioReset Medical Business Overview
      • 10.15.5 BioReset Medical Recent Developments
    • 10.16 IV Boost UK
      • 10.16.1 IV Boost UK Basic Information
      • 10.16.2 IV Boost UK NAD+ Intravenous Therapy Product Overview
      • 10.16.3 IV Boost UK NAD+ Intravenous Therapy Product Market Performance
      • 10.16.4 IV Boost UK Business Overview
      • 10.16.5 IV Boost UK Recent Developments
  • 11 NAD+ Intravenous Therapy Market Forecast by Region
    • 11.1 Global NAD+ Intravenous Therapy Market Size Forecast
    • 11.2 Global NAD+ Intravenous Therapy Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe NAD+ Intravenous Therapy Market Size Forecast by Country
      • 11.2.3 Asia Pacific NAD+ Intravenous Therapy Market Size Forecast by Region
      • 11.2.4 South America NAD+ Intravenous Therapy Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of NAD+ Intravenous Therapy by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global NAD+ Intravenous Therapy Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of NAD+ Intravenous Therapy by Type (2026-2035)
      • 12.1.2 Global NAD+ Intravenous Therapy Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of NAD+ Intravenous Therapy by Type (2026-2035)
    • 12.2 Global NAD+ Intravenous Therapy Market Forecast by Application (2026-2035)
      • 12.2.1 Global NAD+ Intravenous Therapy Sales (K MT) Forecast by Application
      • 12.2.2 Global NAD+ Intravenous Therapy Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.